The series will start on Sunday February 27th when Katie Ford MRCVS, who is also a life coach, will discuss the benefits of 'gratitude practice' in a 'Facebook Live' session starting at 8:00pm.
Thereafter, there will be a further seven 30-minute sessions:
Liz Barton, co-founder of WellVet, said: "We were blown away by the positive response to the Winter Wellbeing series and want to continue to build more tools and content to help people through what has already been a tough start to 2021. Our emphasis is on simple, practical, accessible tips to improve personal and team wellbeing.”
Emma McAnally, territory manager at Boehringer Ingelheim Animal Health said: “Spring is the ideal time to hit refresh on your mental and physical wellbeing. So we felt that this series will help to shed the winter blues, re-energise the team and offer an opportunity for the veterinary community to come together and take forward positive wellbeing practices. We’re delighted to support WellVet again in bringing this Spring series to life.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.
The RCVS Officers will be heading to Somerset, home ground of President Bob Moore, on Thursday 22 May for RCVS Question Time.
The Shrubbery Hotel in Ilminster is the venue for the final Regional Question Time of Bob Moore’s Presidential year, where he looks forward to seeing lots of familiar faces for a lively debate.
Veterinary surgeons, veterinary nurses and others involved in the profession are all welcome to attend the meeting, which kicks off at 6:30pm with a relaxing drink, a bite to eat and a chance to catch up with colleagues, followed by Question Time at 7:15pm. The meeting will finish at approximately 10:00pm.
Bob Moore will be chairing the meeting and the panel will be made up of the Officer team and Veterinary Nurses Council Chairman Andrea Jeffery, who will be answering your questions and concerns regarding the veterinary profession.
Hot topics expected to be raised on the night include the RCVS Practice Standards Scheme, a new Veterinary Surgeons Act, RCVS modular certificate, 24-hour cover, the Professional Development Phase and the non-statutory Register for veterinary nurses.
To book your place contact Fiona Clark at the RCVS on 020 7202 0773 or f.clark@rcvs.org.uk before 9 May 2008, or download an invitation at http://www.rcvs.org.uk/ and post it to the address supplied. All veterinary surgeons and veterinary nurses living within reasonable travelling distance of the meeting venue will be sent a personal invitation.
If you are unable to attend the meeting, but have a question you would like to raise, please do write in.
John Swinney MSP, Cabinet Secretary for Finance and Sustainable Growth, oficially opened the award-winning £10.5 million Small Animal Hospital for the Faculty of Veterinary Medicine, University of Glasgow today.
Designed by Archial Architects, the Small Animal Hospital provides state of the art services for animal owners and referring practitioners throughout Scotland and Northern England, including advanced diagnostic, therapeutic and surgical techniques.
Archial's design for the Small Animal Hospital has already won a string of awards, including the prestigious RIAS Andrew Doolan Best Building in Scotland Award, a RIBA Regional Award and the Supreme Award from the Glasgow Institute of Architects.
Archial Architects has confirmed that it is to donate £2,500 from the Andrew Doolan Prize fund to the Small Animal Hospital.
Novartis Animal Health has announced that Crovect 1.25% Pour-On solution for sheep, a broad spectrum ectoparasiticide, is now licenced for the treatment of ticks, with a persistent efficacy of ten weeks and the majority killed within three hours.
Crovect also works in the treatment and control of headflies, the treatment of biting lice, and the prevention and treatment of blowfly strike in sheep.
Crovect has a meat withhold period of eight days. Novartis says this makes Crovect the long-lasting tick treatment with the shortest meat withhold period available, which is of use to farmers taking lambs to market at this time of year.
Helen Langham, Brand Manager at Novartis Animal Health said: "Farmers now have another option available for effective and long lasting tick treatment for their flocks, and one that can be flexibly used in lambs to be marketed. This should greatly reduce the worry of tick infestation along with the associated welfare and economic problems, and we are pleased to bring this solution to the market".
National Veterinary Services has launched NVS Webshop, an online veterinary shop that practices can bolt on to their own website, or setup as a standalone online shop.
NVS says the shop, which is branded with your practice livery, includes the following features:
For more information visit: http://www.vet2pet.co.uk, email: salesandmarketing@nvs-ltd.co.uk or call 01782 770326.
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."
The RCVS has launched a survey asking recent graduates from UK veterinary schools to share their experiences of the role played by extra-mural studies (EMS) while studying for their degree.
The aim of the online survey, which has been emailed to all of the 2012 and 2013 UK veterinary graduates for whom the College holds email addresses, is to take a snapshot of how EMS placements - whether pre-clinical or clinical - are working in practice and their value in educational terms.
Christine Warman, RCVS Head of Education, said: "In 2009 we carried out a review into EMS arrangements and, in light of this, we want to gather evidence on current practice in order to build up a picture of how EMS is now working and the role that it plays in the learning process for veterinary students. This evidence will inform any future discussions about EMS.
"So, for example, we would like to find out what students gained from EMS that they could not have learnt from their core studies alone and gather further information on the process of identifying and arranging EMS placements."
Recent graduates taking part in the survey, which takes around 10 to 15 minutes to complete, can supply their name and email address or, alternatively, there is the option of responding anonymously. The survey should be completed by Friday 14 February. Those 2012 and 2013 graduates who have not received an email with the link to the survey, and who wish to take part, should email: education@rcvs.org.uk
For more information on EMS, or the survey, contact the RCVS Education Department on 020 7202 0791 or education@rcvs.org.uk. Further guidance about EMS for both students and placement providers can be found at www.rcvs.org.uk/ems which includes a link to the RCVS Find a Vet service where students can search for practices providing EMS.
The traditional method for detecting equine lameness is subjective, using expert visual evaluation of gait to identify the presence or absence and degree of asymmetries. The lame horse is described as having a disorder, defect or loss of function and this clinical diagnosis has associated welfare implications if the horse is still asked to perform.
The article explains how advanced computer technology is starting to change all this. Optic motion capture or the use of inertial measurement units (IMUs) is now enabling the detailed study and quantification of the horse’s gait; objective assessment against preset thresholds. The paper points out that while these digital systems can overcome the temporal and spatial limitations of the human eye they simply rely on one or a number of set gait parameters to decide about lameness and this can present obstacles.
Thresholds are forcibly based on a limited reference population, which doesn’t adequately reflect the millions of horses in the world. The individual environmental and mental conditions for each horse and its day-to-day gait variations are also not accounted for. On this basis to use the term ‘lame’ because a horse demonstrates a subtle gait alteration, causing it to fall below the threshold, could be inappropriate, particularly as it may not affect the horse’s welfare in any way.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "An important first step is for researchers and clinicians to start to discriminate clearly between 'asymmetry' and 'lameness' and not to use these as interchangeable terms when interpreting gait analysis data. Asymmetry is often, but not always, a hallmark of lameness, but is not a clinical term, whereas lameness is."
The company says the workshop will provide vets with an opportunity to extend their knowledge of Q Fever, a zoonotic disease that not only affects reproductive performance and productivity in cattle but also presents a health threat to farmers, farming families and related professions such as vets, veterinary technicians and abattoir workers.
The workshop will be presented by Raphaël Guatteo (pictured right), Professor in Bovine Medicine and Health Management at the Veterinary College of Nantes (Oniris) in France.
Raphaël will share his wealth of knowledge on Q Fever including his extensive research into the disease.
He'll answer any questions that delegates may have about Q Fever and will discuss case studies, diagnostic challenges and the importance of quick diagnosis, treatment options and prevention through vaccination.
The Q Fever workshop will take place between 4.00pm and 5.30pm on Thursday 20 October in the Shorthorn Room at the Hilton Metropole in Birmingham.
The workshop is free of charge, but spaces are limited.
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
Data for 2023 from UK Pet Food research found that around 5% of UK households own a reptile, up from 3.4% in 2022.
The new leaflets have been created using information from the BSAVA Manual of Reptiles and reviewed by Simon Girling, reptile specialist at The Royal Zoological Society of Scotland.
They cover things like housing, feeding, handling, medication and spotting health concerns, and are now available for veterinary surgeons to download and print out for clients thinking about getting a reptile.
There are currently leaflets for the following species:
BSAVA members can download the leaflets free from the BSAVA library.
Subscription access for 12 months to BSAVA’s collection of over 170 client information leaflets is available to non-members for £40+VAT here.
The research is being carried out by James Glass MRCVS (pictured), a PhD researcher working in the Suicide Behaviour Research Lab at the University of Glasgow, supervised by Professor Rory O'Connor - current president of the International Association for Suicide Prevention.
To take part, vets and student vets are being asked to complete a 15-25 minute survey, which must be done in one sitting.
Survey answers are strictly confidential.
Everyone is invited to participate, regardless of whether or not you have experienced suicidal thoughts, however James cautions that some of the questions may be upsetting for anyone currently experiencing suicidal feelings, and emphasises that participants are free to withdraw from the study at any point by closing the webpage, whereupon any answers already submitted with be discarded.
The study is open until 31st December 2024.
https://tinyurl.com/StudyTeamVet
Vetoquinol has published a waiting room poster which highlights canine pain, to support Cimalgex.
Robert Simpson, Product Manager for Cimalgex said: "This poster aims to highlight that pain may not be obvious to pet owners and that signs which the owner may believe to be age related, for example stiffness, may actually be behavioural signs of pain. The most common sign of pain is a change in behaviour and so this is an area which we believe needs to be highlighted to the pet owner1.
"This new poster uses a strong image to catch the pet owner's attention which, when combined with its simple message, will prompt the pet owner to ask for further information from the veterinary practice regarding pain to ensure the overall wellbeing of their pet. This poster complements our client leaflet in helping the veterinary practice to assist the pet owner to spot signs of pain which may not be very obvious."
To find out more or to request a waiting room poster for your practice please contact your Vetoquinol Territory Manager or call 01280 825424.
Reference
1. Hellyer P. et al. AAHA/AAFP Pain Management guidelines for Dogs and Cats. J. AM Anim Hosp Assoc 2007; 43: 235-248.
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.
Public Health England (PHE) is urging veterinary surgeons, nurses, other healthcare professionals and the public to become Antibiotic Guardians by visiting antibioticguardian.com and pledging to make better use of antibiotics, to help make sure they work now and in the future.
The website first asks users to choose whether they would like to make a pledge as a member of the public or as a healthcare professional or leader.
Those who pledge as a Healthcare Professional > Veterinary Practitioner can select one of the following pledges:
Those who pledge as a member of the public can elect to do so as an adult, a family member, a pet owner or a farmer.
The available pledges change according to category and those who respond will be asked if PHE can follow-up to confirm they did keep their pledge.
The campaign forms part of activities that support European Antibiotic Awareness Day (EAAD). Dr Diane Ashiru-Oredope, Lead for EAAD 2014 at Public Health England, said: "Everybody can help to tackle antibiotic resistance and we really urge people to help us do this. There is a lot to be done but we can start by making inroads into inappropriate prescribing.
"There are 2 elements to this. One is that we need patients to not always expect to receive an antibiotic for those self-limiting illnesses which are typically caused by viruses. This generally includes those where the symptoms include coughs, runny noses, muscle aches and fever. And the other is for GPs not to feel pressurised into prescribing antibiotics when they aren't really necessary.
"Community pharmacists and their teams also have a key role and should be seen as the first port of call for many winter illnesses caused by viruses. They can also help to manage patients' expectations by explaining the normal duration of these symptoms, what warning signs to look out for and providing effective over the counter treatments that will help relieve the symptoms.
Nicholas Brown, President at the British Society for Antimicrobial Chemotherapy (BSAC), said: "Recently published research in BSAC's Journal, Journal of Antimicrobial Chemotherapy, confirms that despite government recommendations to reduce prescribing for viral illnesses there are still many GPs who do this. Of course GPs don't want their patients to feel unwell but there are many medicines which are available over-the-counter which can really help to reduce symptoms and make people feel better.
"We want to encourage everyone to self-treat as much as possible when it is safe and appropriate to do so. By using antibiotics only when they are needed we can all help to make sure that we keep our antibiotics working for everyone in the future.
"Antibiotic resistance is one the biggest threats to public health and PHE is delivering 4 key aspects of the 5-year UK strategy to help combat antibiotic resistance. These are improving infection prevention and control practices to reduce the number of infections in patients; optimising prescribing practice, improving professional education, training and public engagement and enabling better access to and use of surveillance data."
Children learn lots of important lessons about life, sickness and death from animals and veterinary practitioners. There seems to be an important role here for the profession to educate adult animal owners why antibiotics need to be used carefully both in pets and in humans.
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
The first course will be overseen by Jodie Hughes, an RCVS and European specialist in anaesthesia and analgesia. The hospital’s inaugural resident will be Luisa Oliveira (pictured right), who earlier completed a rotating internship at North West Veterinary Specialists in Cheshire, and, more recently, an anaesthesia-specific one at NDSR.
Jodie said: “Luisa’s residency will comprise mainly the provision of anaesthesia to multiple animal species, ranging from the ‘simpler’ procedures to the most critical and complex, which we frequently encounter in our interventional cardiac procedures and emergency work.
“A significant component of the training will involve the management of pain, both in the acute setting (in the peri-operative period) and in the chronic setting, whilst dealing with our pain clinic patients.
“Luisa will also be trained in the management of emergency and critical care patients and will undergo rotations in other services to better grasp their requirements.
“As we work exclusively with dogs and cats, we will work in close collaboration with several other hospitals in the UK and continental Europe, to complement Luisa’s training with other species.
“As part of this, Luisa will be exposed to multiple advanced techniques, including ultrasound-guided regional nerve blocks and interventional procedures in our pain clinic.
Luisa said: “This is a fantastic opportunity for me to work alongside an incredibly experienced and skilled team at NDSR.
The training programme has been developed by Rui Pinelas, RCVS and European specialist in anaesthesia and analgesia at NDSR, who is optimistic there will be further training opportunities in the near future.
Rui said: “This was something NDSR has been keen to implement for some time and we had been having ongoing discussions to choose the perfect time.
“In terms of logistics, it took around three months for us to set up this anaesthesia residency, which was largely spent organising our partnerships with the other training facilities and undergoing an evaluation as to whether our facilities and case load would meet the specialist board’s strict requirements, which we are delighted they did.”
The 4% increase was approved by the Privy Council and the Department for Environment, Food & Rural Affairs.
Dr Tshidi Gardiner, RCVS Treasurer, said: “As with last year, RCVS Council recognises that we are living in difficult economic times, and have tried to keep the fee increase to a minimum.
"However, it is important that we increase fees in line with inflation, as well as take into account additional related costs, to ensure we are fulfilling our regulatory remit to the best of our abilities and meet our strategic priorities.”
Veterinary surgeons need to pay their annual renewal by 1st April and will be sent their fee notices within the first two weeks of March.
Anyone who has not paid their fee by 1st May will incur a higher fee charge of £36, with non-payment by 1st June risking removal from the Register and ineligibility to practise.
As part of the annual renewal process, all individual vets will also need to log into their online MyAccount to confirm their registration and contact details and declare any convictions.
Anyone who expects to encounter any difficulties in paying their fees should contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
The University of Liverpool’s Philip Leverhulme Equine Hospital has installed a standing equine MRI scanner from Hallmarq Veterinary Imaging.
The RCVS Trust has announced 34 grants totalling approximately £165,000, being made to veterinary surgeons, universities and higher education (HE) establishments, to fund high-quality research projects in the UK and overseas, and support veterinary education.
Harper Adams University College and Myerscough College will be the first veterinary nursing colleges to receive funding under the Spencer-Hill equipment grants programme; this was the first time that RCVS-approved HE veterinary nurse training providers were able to apply for this funding. Harper Adams will receive £2,350 to purchase a Humphrey ADE-circle system, and Myerscough, £1,395 for an 'Emily' canine positioning mannequin.
Severine Tasker MRCVS, from the University of Bristol, and Janet Patterson-Kane MRCVS, from the University of Glasgow each received Blue Sky Awards of £17,000. Severine will conduct research into constructing defined feline coronavirus strains for determination of the role of virus genetics in the development of feline infectious peritonitis. Janet Patterson-Kane's research will investigate whether a new therapy for treating wounds in humans can be translated for use in horses.
Janet said: "Limb wounds in horses are very common and are notorious for developing masses of exuberant scar tissue - proud flesh - and not healing properly. This can necessitate multiple operations. The findings of current research at University College London by our collaborator, Professor David Becker, suggest that in human patients a protein, connexin 43, is not downregulated at the edges of wounds that are difficult to heal. Use of therapy to reduce connexin 43 expression in human skin wounds in which healing has stalled has been remarkably successful in achieving wound closure. The aim of our research is to determine if connexin 43 plays a similar key role as a 'master switch' for wound healing in horses. I am extremely grateful to the RCVS Trust for their support."
Six veterinary undergraduates will also receive EMS vacation research scholarships of £700 each, which can be used to fund expenses relating to a research project undertaken in the UK or overseas as part of a UK veterinary school's extra-mural studies requirement.
Full details of the RCVS Trust grant awards may be found at www.rcvstrust.org.uk/awards
Horiba Medical has announced it is the official exclusive UK distributor of the fully automated Vet abc Plus+ veterinary haematology analyser from scil animal care company GmbH, Germany.
According to the company, the compact Vet abc Plus+ provides a complete blood count (CBC), including 4-part white blood cell (WBC) differential, from only 10 µl of EDTA whole blood, in only 60 seconds.
The Vet abc Plus+ provides pre-installed settings to analyse samples from dogs, cats, horses, rabbits, mice, rats, cattle, pigs and sheep. For dogs, cats and horses, the Vet abc Plus+ provides a 4-part WBC differential blood count, including a differentiation of the leucocytes to identify lymphocytes, monocytes, granulocytes and eosinophils. Results are available in 60 seconds on screen or can be automatically printed out and transferred to the practice information system or clinical notes. For ease-of-use, the Vet abc Plus+ also incorporates a self-contained reagent and waste system which provides a clean operation whilst being easy to replenish.
Borne from an existing manufacturing partnership, scil and HORIBA Medical already have over 6000 veterinary haematology analysers placed globally. Horiba says the new UK distribution agreement enables UK veterinary professionals to not only procure the Vet abc Plus+ analyser, but also receive expert service and support directly from the manufacturer HORIBA Medical and its team of UK specialists.
For more information, visit: www.horiba.com/uk/medical
A new veterinary charity is offering veterinary surgeons, nurses and others in the profession the chance to get fit and raise money for Hounds for Heroes, SPANA and the Pet Blood Bank later this year.
The Vet Charity Challenge (VCC) is looking for teams to take part in a one-day event, involving a series of physical tasks and puzzle-solving challenges along the way, so it requires a bit of brain as well as brawn. The course will feature walking / running, cycling and kayaking and anyone can take part at whatever fitness level.
As well as raising money for the charities, organisers say it will be a fun way to build up camaraderie among your colleagues outside of the work environment and also a local PR opportunity for your practice or business to enhance your community profile.
The event is expecting to raise in excess of £30,000 for charity, but organisers stress that it will need the support of and participation by the veterinary profession to ensure it is a success.
The challenge will take place on Saturday 15th September 2012 at the Royal Agricultural College, Cirencester and all details may be found on http://www.vetcharitychallenge.co.uk/. Alternatively, ring 01727 859259 for further information. The VCC says an early commitment to take part is essential and the fine detail of training can be worked out later. The VCC will provide training guidelines and help you and your team prepare itself.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse UK Ltd and Vets 2 and is supported by the VPMA, Mojo Consultancy and JCA Media Group.
Sue, who is President of the European Society of Dermatology and an RCVS Specialist, says in a video interview that antimicrobial resistance (AMR) is making otitis externa cases difficult to resolve and that vets can help overcome the problem by rethinking their first line prescription choices.
In the video, created in conjunction with Elanco Animal Health (maker of Osurnia), Sue said: "It’s a sad thing to say but if everybody did manage cases of otitis externa appropriately first time, I probably wouldn’t have a job at all."
"Many of the cases I see as a referral clinician are longstanding cases with very severe, multiply-resistant infections. If we get these cases right on the first occasion with appropriate prescription of drugs, and we don’t hurt dogs so we can give ongoing treatment, then we’d never ever see pseudomonas infection again."
Sue believes part of the problem is that veterinary surgeons are incorrectly saving some of their best first-line treatments for difficult cases. This is perpetuating the antimicrobial resistance problem as cases are being inadvertently mismanaged.
She said: "Florfenicol, which is the active antibiotic in Osurnia, has excellent gram positive activity which makes it an ideal first line choice. However, there’s a misconception that florfenicol is a fluoroquinolone - which it isn’t - so vets are incorrectly ‘saving it’ rather than using it on the first occasion."
Sue also highlights that poor compliance, resulting from the patient’s behavioural problems associated with ear phobia, also has a long-term impact:
"We’ve seen many 'well behaved' dogs that have bitten their owners as a result of fear aggression; we’ve had dogs that have pinned their owners against the wall. I would argue very strongly that if you use long-acting products in dogs on the first occasion then you avoid creating that problem and these dogs don’t become difficult to medicate on a long-term basis."
Sue summarised two factors that vets need to consider when deciding on the appropriate treatment: the right active ingredients to target common first-line pathogens; and the method of application. She urged vets to consider using a long-acting product applied within the practice, removing the need for home treatment to reduce stress for both owner and the dog, improve long-term compliance and maximise clinical outcomes.
To hear Sue’s tips on how to treat cases of otitis, watch the video here – www.osurnia.co.uk
Melvyn was instrumental in shaping the success of the Trap, Neuter, Return, method of controlling feral cat populations. After meeting 60's supermodel Celia Hammond, scientist Dr. Jenny Remfry, and Peter Neville, a research biologist for UFAW, acted on their requests for better and more humane traps and engineered his first trap - the Eziset.
Melvyn went on to develop a dog grasper and a wide range of other handling products widely used in veterinary practice. He then developed the Mikki Muzzle, on the back of which he launched Mikki Pet Products, adding a range of grooming products.
In 1998, Melvyn sold Mikki to focus on his real passion – developing high welfare animal handling equipment and products sold via MDC Exports.
Ian MacFarlaine RVN said: "His impact on the veterinary world is only eclipsed by how much of a contribution he's made to animal charities globally, not just in inventing stuff, but then discounting it readily (through good and bad economic times) and then if that wasn't enough, giving thousands of pounds worth of it away at the ICAWC conference every year.
"If you were privileged enough to know him well, then you'll miss the kindness, the mischievous humour and the occasional bad taste joke. But I can guarantee that a little bit of Melvyn is there in each and every one of your practices in the form of one piece of equipment or other."